KALA BIO, Inc. SEC filings and other documents

Explore the latest company documents and SEC filings from KALA BIO, Inc., including Forms 10-K, 10-Q, 8-K, and other key disclosures. Evaluate financial performance and operational updates to make more informed decisions.

Description

Event date

Documents and forms

2025

H.C. Wainwright 27th Annual Global Investment Conference

Sep 10, 2025

Transcript

H.C. Wainwright 5th Annual Ophthalmology Virtual Conference

Aug 13, 2025

Transcript

Q2 2025

Aug 8, 2025

Quarterly report10-Q

Earnings release8-K

Status Update

Jul 16, 2025

Slides

Q1 2025

May 14, 2025

Quarterly report10-Q

Earnings release8-K

2024

Q4 2024

Mar 31, 2025

Annual report10-K

Earnings release8-K

Q3 2024

Nov 12, 2024

Quarterly report10-Q

Earnings release8-K

Q2 2024

Aug 6, 2024

Quarterly report10-Q

Earnings release8-K

Q1 2024

May 14, 2024

Quarterly report10-Q

Earnings release8-K

2023

Q4 2023

Mar 29, 2024

Earnings release8-K

Annual report10-K

Q3 2023

Nov 13, 2023

Quarterly report10-Q

Earnings release8-K

Q2 2023

Aug 4, 2023

Quarterly report10-Q

Earnings release8-K

Q1 2023

May 9, 2023

Quarterly report10-Q

Earnings release8-K

2022

Q4 2022

Mar 3, 2023

Annual report10-K

Earnings release8-K

Q3 2022

Nov 8, 2022

Quarterly report10-Q

Earnings release8-K

Q2 2022

Aug 11, 2022

Quarterly report10-Q

Earnings release8-K

Slides

Q1 2022

May 16, 2022

Quarterly report10-Q

2021

Q4 2021

Mar 29, 2022

Annual report10-K

2020

Q4 2020

Feb 25, 2021

Annual report10-K

2019

Q4 2019

Feb 12, 2020

Annual report10-K

2018

Q4 2018

Mar 12, 2019

Annual report10-K

2017

Q4 2017

Apr 2, 2018

Annual report10-K